Clinical trials
Withdrawn Phase 1 Parkinson Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| 4D pharma plc | 1 |
| AbbVie | 1 |
| Affiris AG | 1 |
| CuraSen Therapeutics, Inc. | 1 |
| Enterin Inc. | 1 |
| Inflazome UK Ltd | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Nader Pouratian | 1 |
| Nathaniel M. Robbins | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 14 |
| Anosmia | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Hallucinations | 1 |
| Hypotension, Orthostatic | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.